| abstract |
Hyperlipemia and related symptoms such as CHD, ischemic attack, restenosis after angioplasty, peripheral vascular disease, intermittent claudication, myocardial infarction (eg, necrosis and apoptosis), dyslipidemia and postprandial lipidemia and The composition is disclosed. The method comprises administration of a therapeutically effective amount and a pharmaceutically acceptable carrier in free form or in acid addition salt form of a compound of formula (I).n n n <Formula I>n n n n n n n n Wheren n n R is substituted adamantyl;n n n n is 0-3. |